• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Morgan Stanley

Hansen Medical slips on Morgan Stanley suspension

January 11, 2016 By Brad Perriello

Shares of Hansen Medical (NSDQ:HNSN) slid last week after an analyst at Morgan Stanley said he would stop covering the robot-assisted surgery device maker, citing competitive issues and a capitalization problem. “We expect Hansen to underperform our coverage and the broader market largely due to our view that Hansen’s penetration into endovascular procedures will have a much slower […]

Filed Under: Robotics, Wall Street Beat Tagged With: Hansen Medical Inc., Morgan Stanley

Stryker evaluates acquisition of orthopedics rival Smith & Nephew | Medtech Wall Street news for the week of June 2, 2014

June 5, 2014 By MassDevice Leave a Comment

What if Stryker bought Smith & Nephew?

May 29, 2014 by Brad Perriello

What if Stryker bought Smith & Nephew?

Stryker CEO Kevin Lobo yesterday admitted that his company was evaluating an acquisition of British orthopedics rival Smith & Nephew.

Filed Under: News Well, Wall Street Beat Tagged With: Allergan, Morgan Stanley, Pershing Square Capital Management, Smith & Nephew, Stryker, Valeant Pharmaceuticals

What if Stryker bought Smith & Nephew?

May 29, 2014 By Brad Perriello Leave a Comment

What if Stryker bought Smith & Nephew?

Filed Under: Mergers & Acquisitions, News Well, Orthopedics, Wall Street Beat Tagged With: Morgan Stanley, Smith & Nephew, Stryker

CFN taps BSX exec for board | Medtech personnel moves for the week of May 12, 2014

May 14, 2014 By MassDevice Leave a Comment

CareFusion taps Boston Scientific exec Bose for board | Personnel Moves

May 9, 2014 by Brad Perriello

YYmeta

Filed Under: News Well Tagged With: AdvaMed, Alphaeon, Aurora Spine, Boston Scientific, Bovie Medical Corp., CareFusion Corp., Elekta, Morgan Stanley, neovasc, OrthoAccel Technologies Inc., Personnel Moves, rotationmedical, Unilife Corp., wrightmedical

Medtech makers continue shift in CEO pay

May 8, 2014 By Brad Perriello Leave a Comment

Medtech makers continue shift in CEO pay

Image © 2014 Morgan Stanley. Click image to enlarge.

Filed Under: News Well Tagged With: Executive Compensation, Morgan Stanley, Personnel Moves

Teleflex announces plans to cut costs and streamline manufacturing | Medtech Wall Street news for the week of May 5, 2014

May 8, 2014 By MassDevice Leave a Comment

Teleflex plans layoffs, plant closures in response to ‘cost pressures’

May 2, 2014 by Arezu Sarvestani

Teleflex plans layoffs, plant closures in response to 'cost pressures'

Filed Under: News Well, Wall Street Beat Tagged With: Accuray Inc., Cardiovascular Systems Inc., Edwards Lifesciences, Endo Health, GI Dynamics, Hansen Medical Inc., Intuitive Surgical, Johnson and Johnson, Morgan Stanley, Teleflex, Zimmer Biomet

Morgan Stanley: Medtech underperformed in April

May 5, 2014 By Brad Perriello Leave a Comment

Morgan Stanley: Medtech underperformed in April

The medical device sector under-performed the S&P 500 index in April after a sharp swing over-performance during the 1st quarter, according to analysts at Morgan Stanley.

The 30 medtech stocks Morgan Stanley covers collectively under-performed the S&P by 4.1%, after besting the index by 4.9% during the 1st quarter.

Filed Under: News Well, Wall Street Beat Tagged With: Accuray Inc., Edwards Lifesciences, Hansen Medical Inc., Intuitive Surgical, Johnson and Johnson, Morgan Stanley, Zimmer Biomet

Medtronic CFO: Size matters

September 11, 2012 By MassDevice staff Leave a Comment

Medtronic logo

Medtronic (NYSE:MDT) is better prepared than its competitors to adapt to changing environments in the global healthcare system, CFO Gary Ellis told investors today.

Filed Under: News Well, Wall Street Beat Tagged With: Cardiac Rhythm Management, Morgan Stanley

Abbott details $15B AbbVie spinout financing | Wall Street Beat

June 21, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Abbott (NYSE:ABT) is putting a $14.5 billion financing package in place to back the spinout of its research pharmaceuticals division into a separate company called AbbVie.

Filed Under: Funding Roundup, News Well, Wall Street Beat Tagged With: Abbott, AbbVie, Bank of America Merrill Lynch, China Medical Technologies, Johnson and Johnson, JP Morgan Chase, Morgan Stanley, Nuvasive, Organogenesis Inc.

MassDevice.com +7 | The top 7 med-tech stories for the week of June 1, 2012.

June 1, 2012 By MassDevice staff Leave a Comment

Plus Seven

Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.

Filed Under: Healthcare Reform, News Well Tagged With: Cook Group Inc., Morgan Stanley, Plus 7, U.S. Congress, U.S. House of Representatives, U.S. Senate

Morgan Stanley: “Device tax likely won’t be repealed on this attempt”

June 1, 2012 By Arezu Sarvestani Leave a Comment

Morgan Stanely illustration

Morgan Stanley analysts are slightly more confident this month that the medical device tax might be repealed, but they don’t see it happening this year.

The odds of repeal are up to 30% from just 10% last month, according to a report published by the financial services firm, but the measure isn’t likely to make it through the Democrat-led Senate. But the fight won’t end there.

Filed Under: Healthcare Reform, News Well Tagged With: Morgan Stanley, U.S. Congress, U.S. House of Representatives

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS